Cargando…

Evaluation of the radiosensitizing effect of MEK inhibitor KZ-001 on non-small cell lung cancer cells in vitro

BACKGROUND: Non-small cell lung cancer (NSCLC) has a poor prognosis and usually presents resistance against radiotherapy. MEK inhibitors have been proven to possess a radiosensitization effect. The compound KZ-001 as a particular MEK inhibitor is superior to the listed MEK inhibitor AZD6244. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Gongchao, Zhang, Wenqin, Tian, Hongqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602635/ https://www.ncbi.nlm.nih.gov/pubmed/37899758 http://dx.doi.org/10.2478/abm-2023-0064

Ejemplares similares

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
por: Liu, Yahong, et al.
Publicado: (2023)

MEK inhibitors for the treatment of non-small cell lung cancer
por: Han, Jing, et al.
Publicado: (2021)

Phage phiKZ—The First of Giants
por: Krylov, Victor, et al.
Publicado: (2021)

Current Development Status of MEK Inhibitors
por: Cheng, Ying, et al.
Publicado: (2017)

Structure of the bacteriophage PhiKZ non-virion RNA polymerase
por: de Martín Garrido, Natàlia, et al.
Publicado: (2021)

Library of Congress classification. KZ. Law of nations /
Publicado: (1998)

MEK inhibitors against MET-amplified non-small cell lung cancer
por: Chiba, Masato, et al.
Publicado: (2016)

Correction to ‘Structure of the bacteriophage PhiKZ non-virion RNA polymerase’
por: de Martín Garrido, Natàlia, et al.
Publicado: (2021)

Library of Congress classes JZ and KZ : historical notes and introduction to application /
por: Goldberg, Jolande E.
Publicado: (1997)

Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
por: Cron, Kyle R., et al.
Publicado: (2013)

RRx-001, A novel dinitroazetidine radiosensitizer
por: Oronsky, Bryan, et al.
Publicado: (2016)

Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells
por: Iezzi, Alice, et al.
Publicado: (2018)

Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells
por: Tanizaki, J, et al.
Publicado: (2012)

Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status
por: Van den Bossche, Jolien, et al.
Publicado: (2019)

Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer
por: Haslett, K., et al.
Publicado: (2021)

Suppresses of LIM kinase 2 promotes radiosensitivity in radioresistant non-small cell lung cancer cells
por: Tian, Chao, et al.
Publicado: (2023)

HER3 expression and MEK activation in non-small-cell lung carcinoma
por: Manickavasagar, Thubeena, et al.
Publicado: (2021)

Dual Active Site in the Endolytic Transglycosylase gp144 of Bacteriophage phiKZ
por: Chertkov, O.V., et al.
Publicado: (2017)

Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
por: Chen, Xu, et al.
Publicado: (2016)

Inhibition of PC4 radiosensitizes non‐small cell lung cancer by transcriptionally suppressing XLF
por: Zhang, Tian, et al.
Publicado: (2018)

Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo
por: Meng, Jieru, et al.
Publicado: (2010)

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro
por: Xie, Bo, et al.
Publicado: (2018)

Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer
por: Wang, Cui, et al.
Publicado: (2018)

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
por: Ramesh, Shrey, et al.
Publicado: (2023)

MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
por: Ma, Debin, et al.
Publicado: (2015)

ACT001 inhibits the proliferation of non‐small cell lung cancer cells by upregulating NKTR expression
por: Zhao, Min, et al.
Publicado: (2022)

Maturation of Pseudo-Nucleus Compartment in P. aeruginosa, Infected with Giant phiKZ Phage
por: Danilova, Yana A., et al.
Publicado: (2020)

Draft Genome Sequence of Lactobacillus salivarius KZ-NCB, Isolated from Chicken Cecum
por: Kirillov, Saveliy, et al.
Publicado: (2020)

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro [Erratum]
Publicado: (2018)

Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer
por: Xu, Qiushi, et al.
Publicado: (2022)

Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer
por: Cunningham, Charnay, et al.
Publicado: (2023)

MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
por: Fanini, Francesca, et al.
Publicado: (2021)

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule
por: Grabenbauer, Felix, et al.
Publicado: (2018)

hMOF reduction enhances radiosensitivity through the homologous recombination pathway in non-small-cell lung cancer
por: Li, Nan, et al.
Publicado: (2019)

Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated
por: Park, Soo-Yeon, et al.
Publicado: (2010)

SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer
por: Cao, Rubo, et al.
Publicado: (2013)

Silencing of heat shock protein 27 increases the radiosensitivity of non-small cell lung carcinoma cells
por: Xu, Liping, et al.
Publicado: (2019)

Radiosensitization effects of curcumin plus cisplatin on non-small cell lung cancer A549 cells
por: Cai, Yong, et al.
Publicado: (2019)

In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
por: Shaw, Karen Joy, et al.
Publicado: (2018)

Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma
por: Zhao, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v485omku8rbmu1t8f2qtag46nh